Gene Expression Profiling Combined with Bioinformatics Analysis Identify Biomarkers for Parkinson Disease

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Diao, Hongyu ^a   Li, Xinxing ^a   Hu, Sheng ^b   Liu, Yunhui ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b Department of Neurosurgery   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; EARLY GROWTH RESPONSE FACTOR 3; HEPATIC LEUKEMIA FACTOR; STAT4 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR NKX3.1; TRANSCRIPTION FACTOR RFX1; TRANSCRIPTION FACTOR TAL1; UNCLASSIFIED DRUG;

AGED; ARTICLE; BIOINFORMATICS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; E2F1 GENE; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE MAPPING; GENE REGULATORY NETWORK; GENE TARGETING; GENETIC ASSOCIATION; GENETIC DATABASE; GENETIC VARIABILITY; HLF GENE; HUMAN; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PROTEIN METABOLISM;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; BIOLOGICAL MARKERS; COMPUTATIONAL BIOLOGY; DNA-BINDING PROTEINS; E2F1 TRANSCRIPTION FACTOR; EARLY GROWTH RESPONSE PROTEIN 3; GENE EXPRESSION PROFILING; HOMEODOMAIN PROTEINS; HUMANS; PARKINSON DISEASE; PROTO-ONCOGENE PROTEINS; STAT4 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTORS;

EID: 84871675217     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052319     Document Type: Article

References (43)

1. Foulds P, Mann DM, Mitchell JD, Allsop D, (2010) Parkinson disease: Progress towards a molecular biomarker for Parkinson disease. Nat Rev Neurol 6: 359-361.
2. Jankovic J, (2008) Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 79: 368-376.
3. Elbaz A, Dufouil C, Alperovitch A, (2007) Interaction between genes and environment in neurodegenerative diseases. C R Biol 330: 318-328.
4. Douglas PM, Dillin A, (2010) Protein homeostasis and aging in neurodegeneration. J Cell Biol 190: 719-729.
5. Chade AR, Kasten M, Tanner CM (2006) Nongenetic causes of Parkinson's disease. J Neural Transm Suppl 70: 147-151.
6. Hashimoto M, Masliah E, (1999) Alpha-synuclein in Lewy body disease and Alzheimer's disease. Brain Pathol 9: 707-720.
7. Hatano T, Kubo S, Sato S, Hattori N, (2009) Pathogenesis of familial Parkinson's disease: new insights based on monogenic forms of Parkinson's disease. J Neurochem 111: 1075-1093.
8. Devic I, Hwang H, Edgar JS, Izutsu K, Presland R, et al. (2011) Salivary alpha-synuclein and DJ-1: potential biomarkers for Parkinson's disease. Brain 134: e178.
9. Waragai M, Wei J, Fujita M, Nakai M, Ho GJ, et al. (2006) Increased level of DJ-1 in the cerebrospinal fluids of sporadic Parkinson's disease. Biochem Biophys Res Commun 345: 967-972.
10. Maita C, Tsuji S, Yabe I, Hamada S, Ogata A, et al. (2008) Secretion of DJ-1 into the serum of patients with Parkinson's disease. Neurosci Lett 431: 86-89.
11. Tokuda T, Salem SA, Allsop D, Mizuno T, Nakagawa M, et al. (2006) Decreased alpha-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease. Biochem Biophys Res Commun 349: 162-166.
12. Ohrfelt A, Grognet P, Andreasen N, Wallin A, Vanmechelen E, et al. (2009) Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss? Neurosci Lett 450: 332-335.
13. Hong Z, Shi M, Chung KA, Quinn JF, Peskind ER, et al. (2010) DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease. Brain 133: 713-726.
14. Nagatsu T, Sawada M, (2005) Inflammatory process in Parkinson's disease: role for cytokines. Curr Pharm Des 11: 999-1016.
15. Sato S, Mizuno Y, Hattori N, (2005) Urinary 8-hydroxydeoxyguanosine levels as a biomarker for progression of Parkinson disease. Neurology 64: 1081-1083.
16. Godau J, Herfurth M, Kattner B, Gasser T, Berg D, (2010) Increased serum insulin-like growth factor 1 in early idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 81: 536-538.
17. Kanehisa M (2002) The KEGG database. Novartis Foundation symposium 247: 91-101; discussion 101-103, 119-128, 244-152.
18. Kanehisa M, Goto S, (2000) KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28: 27-30.
19. Stuart JM, Segal E, Koller D, Kim SK, (2003) A gene-coexpression network for global discovery of conserved genetic modules. Science 302: 249-255.
20. Lee HK, Hsu AK, Sajdak J, Qin J, Pavlidis P, (2004) Coexpression analysis of human genes across many microarray data sets. Genome Res 14: 1085-1094.
21. Bergmann S, Ihmels J, Barkai N, (2004) Similarities and differences in genome-wide expression data of six organisms. PLoS Biol 2: E9.
22. Liu BH, Yu H, Tu K, Li C, Li YX, et al. (2010) DCGL: an R package for identifying differentially coexpressed genes and links from gene expression microarray data. Bioinformatics 26: 2637-2638.
23. Yu H, Liu BH, Ye ZQ, Li C, Li YX, et al. (2011) Link-based quantitative methods to identify differentially coexpressed genes and gene pairs. BMC Bioinformatics 12: 315.
24. Team RDC (2011) R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing.
25. Benjamini Y, Hochberg Y, (1995) Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the royal statistical society Series B (Methodological) 57: 289-300.
26. Huang da W, Sherman BT, Lempicki RA, (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
27. Reverter A, Hudson NJ, Nagaraj SH, Perez-Enciso M, Dalrymple BP, (2010) Regulatory impact factors: unraveling the transcriptional regulation of complex traits from expression data. Bioinformatics 26: 896-904.
28. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, et al. (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13: 2498-2504.
29. Cooper CS, Campbell C, Jhavar S, (2007) Mechanisms of Disease: biomarkers and molecular targets from microarray gene expression studies in prostate cancer. Nat Clin Pract Urol 4: 677-687.
30. Scherzer CR, Eklund AC, Morse LJ, Liao Z, Locascio JJ, et al. (2007) Molecular markers of early Parkinson's disease based on gene expression in blood. Proc Natl Acad Sci U S A 104: 955-960.
31. Guttula SV, Allam A, Gumpeny RS, (2012) Analyzing microarray data of Alzheimer's using cluster analysis to identify the biomarker genes. Int J Alzheimers Dis 2012: 649456.
32. Honda H, Inaba T, Suzuki T, Oda H, Ebihara Y, et al. (1999) Expression of E2A-HLF chimeric protein induced T-cell apoptosis, B-cell maturation arrest, and development of acute lymphoblastic leukemia. Blood 93: 2780-2790.
33. Inaba T, Roberts WM, Shapiro LH, Jolly KW, Raimondi SC, et al. (1992) Fusion of the leucine zipper gene HLF to the E2A gene in human acute B-lineage leukemia. Science 257: 531-534.
34. Hitzler JK, Soares HD, Drolet DW, Inaba T, O'Connel S, et al. (1999) Expression patterns of the hepatic leukemia factor gene in the nervous system of developing and adult mice. Brain Res 820: 1-11.
35. Hou ST, Xie X, Baggley A, Park DS, Chen G, et al. (2002) Activation of the Rb/E2F1 pathway by the nonproliferative p38 MAPK during Fas (APO1/CD95)-mediated neuronal apoptosis. J Biol Chem 277: 48764-48770.
36. Jiang SX, Sheldrick M, Desbois A, Slinn J, Hou ST, (2007) Neuropilin-1 is a direct target of the transcription factor E2F1 during cerebral ischemia-induced neuronal death in vivo. Mol Cell Biol 27: 1696-1705.
37. Smith RA, Walker T, Xie X, Hou ST, (2003) Involvement of the transcription factor E2F1/Rb in kainic acid-induced death of murine cerebellar granule cells. Brain Res Mol Brain Res 116: 70-79.
38. Hoglinger GU, Breunig JJ, Depboylu C, Rouaux C, Michel PP, et al. (2007) The pRb/E2F cell-cycle pathway mediates cell death in Parkinson's disease. Proc Natl Acad Sci U S A 104: 3585-3590.
39. Gehrke S, Imai Y, Sokol N, Lu B, (2010) Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression. Nature 466: 637-641.
40. Yamamoto K, Quelle FW, Thierfelder WE, Kreider BL, Gilbert DJ, et al. (1994) Stat4, a novel gamma interferon activation site-binding protein expressed in early myeloid differentiation. Mol Cell Biol 14: 4342-4349.
41. Bacon CM, Petricoin EF, 3rd, Ortaldo JR, Rees RC, Larner AC, et al (1995) Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes. Proc Natl Acad Sci U S A 92: 7307-7311.
42. Rubinsztein DC, (2006) The roles of intracellular protein-degradation pathways in neurodegeneration. Nature 443: 780-786.
43. Davie CA, (2008) A review of Parkinson's disease. Br Med Bull 86: 109-127.